Clinical Trial Update: Combination of Thrombopoietin Mimetic and Immunosuppressive Therapy in Aplastic Anaemia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating a combination of a thrombopoietin mimetic and immunosuppressive therapy in aplastic anemia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Snippet

Sponsor: Safaa AA Khaled | Conditions: Aplastic Anemia | Phase 4 | Status: COMPLETED